Comerica Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$11.9M Sell
34,056
-2,331
-6% -$788K 0.05% 309
2025
Q3
$11.8M Sell
36,387
-10,684
-23% -$3.32M 0.04% 385
2025
Q2
$18.3M Sell
47,071
-1,162
-2% -$467K 0.07% 278
2025
Q1
$21M Buy
48,233
+1,720
+4% +$690K 0.09% 215
2024
Q4
$17.2M Sell
46,513
-9,460
-17% -$3.96M 0.07% 266
2024
Q3
$29.1M Buy
55,973
+2,217
+4% +$1.18M 0.12% 167
2024
Q2
$29.1M Sell
53,756
-711
-1% -$376K 0.12% 147
2024
Q1
$28.2M Buy
54,467
+1,476
+3% +$734K 0.12% 152
2023
Q4
$25M Sell
52,991
-595
-1% -$275K 0.12% 158
2023
Q3
$23.3M Sell
53,586
-203,277
-79% -$92.2M 0.12% 152
2023
Q2
$39 Buy
+256,863
New +$118M ﹤0.01% 204
2022
Q4
$19.3M Buy
40,167
+4,999
+14% +$2.54M 0.15% 125
2022
Q3
$18.5M Buy
35,168
+911
+3% +$436K 0.16% 109
2022
Q2
$17M Sell
34,257
-425
-1% -$210K 0.14% 116
2022
Q1
$18.4M Sell
34,682
-334
-1% -$153K 0.13% 125
2021
Q4
$15.4M Sell
35,016
-1,649
-4% -$694K 0.11% 156
2021
Q3
$15.9M Sell
36,665
-7,045
-16% -$2.68M 0.1% 192
2021
Q2
$16.4M Sell
43,710
-1,725
-4% -$659K 0.1% 177
2021
Q1
$17.4M Sell
45,435
-5,445
-11% -$1.75M 0.1% 168
2020
Q4
$16M Sell
50,880
-695
-1% -$213K 0.1% 175
2020
Q3
$16M Sell
51,575
-307
-0.6% -$82.6K 0.12% 143
2020
Q2
$13.9M Buy
51,882
+238
+0.5% +$63.5K 0.11% 172
2020
Q1
$13.6M Sell
51,644
-2,785
-5% -$759K 0.13% 141
2019
Q4
$14.5M Sell
54,429
-2,830
-5% -$779K 0.11% 168
2019
Q3
$14.9M Sell
57,259
-1,356
-2% -$372K 0.12% 162
2019
Q2
$17.9M Buy
58,615
+4,270
+8% +$1.17M 0.14% 124
2019
Q1
$15.7M Sell
54,345
-42
-0.1% -$12.1K 0.13% 141
2018
Q4
$14.8M Sell
54,387
-521
-0.9% -$143K 0.13% 147
2018
Q3
$15.1M Sell
54,908
-12,538
-19% -$3.25M 0.12% 157
2018
Q2
$16.6M Sell
67,446
-194
-0.3% -$44.9K 0.12% 163
2018
Q1
$15.4M Sell
67,640
-2,001
-3% -$470K 0.11% 179
2017
Q4
$17.6M Sell
69,641
-5,646
-7% -$1.2M 0.12% 157
2017
Q3
$15.8M Sell
75,287
-448
-0.6% -$85.3K 0.11% 166
2017
Q2
$14.5M Sell
75,735
-93
-0.1% -$16.7K 0.11% 182
2017
Q1
$13.5M Sell
75,828
-868
-1% -$138K 0.1% 192
2016
Q4
$11.4M Buy
76,696
+1,677
+2% +$225K 0.09% 222
2016
Q3
$9.18M Buy
75,019
+2,092
+3% +$270K 0.08% 252
2016
Q2
$9.37M Sell
72,927
-4,635
-6% -$634K 0.08% 239
2016
Q1
$11.1M Buy
77,562
+2,433
+3% +$325K 0.1% 186
2015
Q4
$9.93M Sell
75,129
-1,055
-1% -$145K 0.1% 194
2015
Q3
$10.7M Sell
76,184
-83,730
-52% -$12.6M 0.1% 186
2015
Q2
$26.2M Buy
159,914
+75,985
+91% +$12.1M 0.11% 166
2015
Q1
$13M Buy
+83,929
New +$11.9M 0.11% 176
2014
Q4
Sell
-89,609
Closed -$10.7M 2048
2014
Q3
$10.7M Sell
89,609
-7,872
-8% -$903K 0.09% 201
2014
Q2
$10.5M Sell
97,481
-27,416
-22% -$2.82M 0.09% 213
2014
Q1
$12.4M Sell
124,897
-15,072
-11% -$1.36M 0.1% 205
2013
Q4
$12.9M Sell
139,969
-35,468
-20% -$3.15M 0.1% 200
2013
Q3
$14.7M Buy
+175,437
New +$15M 0.1% 199

Other funds holding ELV

Comerica Bank's ELV Position: Q4 2025 in Review

Comerica Bank reduced its Elevance Health (ELV) stake by 6.4% in Q4 2025, selling an estimated $788K and leaving 34,056 shares worth $11.9M. The position accounts for 0.05% of the portfolio, ranked #309.

Comerica Bank first reported a position in ELV in Q3 2013 and has held it in 48 quarters since. The position peaked at $29.1M in Q2 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Comerica Bank held 34,056 shares of Elevance Health worth $11.9M as of Q4 2025.
  • Comerica Bank sold 2,331 Elevance Health shares in Q4 2025, an estimated $788K.
  • Elevance Health made up 0.05% of Comerica Bank's portfolio in Q4 2025, its #309 holding.
  • Comerica Bank first reported a position in Elevance Health in Q3 2013 and has held it in 48 quarters since.
  • Comerica Bank's Elevance Health position peaked at $29.1M in Q2 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.